Lecanemab Extension Study for AD Offers Mixed Results Lecanemab Extension Study for AD Offers Mixed Results

The lecanemab open-label extension trial for AD showed no new safety signals, but the placebo roll-over group failed to show the gains seen in the experimental arm.MDedge News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news